{"data":[{"accessionNo":"0001193125-26-445875","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001919246","issuerName":"Pelthos Therapeutics Inc.","ticker":"PTHS","cusip":"171126204","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-10-30","reportingPerson":"Ligand Pharmaceuticals Incorporated","reportingCik":"0000886163","personType":"CO","sharesOwned":5189177.1,"percentOfClass":49.9,"filedAt":"2026-11-03","canonicalUrl":"https://xoomar.com/markets/stocks/pths"},{"accessionNo":"0001193125-26-227121","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001919246","issuerName":"Pelthos Therapeutics Inc.","ticker":"PTHS","cusip":"171126204","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Neil Shahrestani","reportingCik":null,"personType":"IN,HC","sharesOwned":256598,"percentOfClass":7.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pths"},{"accessionNo":"0001193125-26-227121","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001919246","issuerName":"Pelthos Therapeutics Inc.","ticker":"PTHS","cusip":"171126204","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Ikarian Capital, LLC","reportingCik":null,"personType":"IA","sharesOwned":256598,"percentOfClass":7.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/pths"},{"accessionNo":"0001753926-26-000789","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001919246","issuerName":"Pelthos Therapeutics Inc.","ticker":"PTHS","cusip":"171126204","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Maier Joshua Tarlow","reportingCik":null,"personType":"IN","sharesOwned":337026,"percentOfClass":9.9,"filedAt":"2026-05-07","canonicalUrl":"https://xoomar.com/markets/stocks/pths"},{"accessionNo":"0001753926-26-000789","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001919246","issuerName":"Pelthos Therapeutics Inc.","ticker":"PTHS","cusip":"171126204","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"3i Management LLC","reportingCik":null,"personType":"OO","sharesOwned":337026,"percentOfClass":9.9,"filedAt":"2026-05-07","canonicalUrl":"https://xoomar.com/markets/stocks/pths"},{"accessionNo":"0001753926-26-000789","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001919246","issuerName":"Pelthos Therapeutics Inc.","ticker":"PTHS","cusip":"171126204","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"3i, LP","reportingCik":null,"personType":"PN","sharesOwned":337026,"percentOfClass":9.9,"filedAt":"2026-05-07","canonicalUrl":"https://xoomar.com/markets/stocks/pths"},{"accessionNo":"0001193125-26-055097","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001919246","issuerName":"Pelthos Therapeutics Inc.","ticker":"PTHS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Ikarian Capital, LLC","reportingCik":null,"personType":"IA","sharesOwned":255758,"percentOfClass":8.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/pths"},{"accessionNo":"0001193125-26-055097","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001919246","issuerName":"Pelthos Therapeutics Inc.","ticker":"PTHS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Neil Shahrestani","reportingCik":null,"personType":"IN,HC","sharesOwned":255758,"percentOfClass":8.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/pths"},{"accessionNo":"0001753926-26-000273","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001919246","issuerName":"Pelthos Therapeutics Inc.","ticker":"PTHS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"3i, LP","reportingCik":null,"personType":"PN","sharesOwned":318886,"percentOfClass":9.9,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/pths"},{"accessionNo":"0001753926-26-000273","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001919246","issuerName":"Pelthos Therapeutics Inc.","ticker":"PTHS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"3i Management LLC","reportingCik":null,"personType":"OO","sharesOwned":318886,"percentOfClass":9.9,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/pths"},{"accessionNo":"0001753926-26-000273","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001919246","issuerName":"Pelthos Therapeutics Inc.","ticker":"PTHS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Maier Joshua Tarlow","reportingCik":null,"personType":"IN","sharesOwned":318886,"percentOfClass":9.9,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/pths"},{"accessionNo":"0001838556-25-000009","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001919246","issuerName":"Pelthos Therapeutics Inc.","ticker":"PTHS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Murchinson Ltd.","reportingCik":null,"personType":"IA,CO","sharesOwned":280000,"percentOfClass":9.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/pths"},{"accessionNo":"0001838556-25-000009","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001919246","issuerName":"Pelthos Therapeutics Inc.","ticker":"PTHS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Marc Bistricer","reportingCik":null,"personType":"HC,IN","sharesOwned":280000,"percentOfClass":9.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/pths"},{"accessionNo":"0001193125-25-283461","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001919246","issuerName":"Pelthos Therapeutics Inc.","ticker":"PTHS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Ikarian Capital, LLC","reportingCik":null,"personType":"IA","sharesOwned":186408,"percentOfClass":6.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/pths"},{"accessionNo":"0001193125-25-283461","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001919246","issuerName":"Pelthos Therapeutics Inc.","ticker":"PTHS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Neil Shahrestani","reportingCik":null,"personType":"IN,HC","sharesOwned":186408,"percentOfClass":6.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/pths"},{"accessionNo":"0001193125-25-274432","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001919246","issuerName":"Pelthos Therapeutics Inc.","ticker":"PTHS","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"Ligand Pharmaceuticals Incorporated","reportingCik":"0000886163","personType":"CO","sharesOwned":5189177.1,"percentOfClass":49.9,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/pths"}],"updatedAt":"2026-11-04T05:18:29.364Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/pths","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}